← Leaderboards
Michael P. Link
Stanford University
$981,418
Attributed
$981,418
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$981,418 · 4
By mechanism
U10$978,711 · 1
M01$2,707 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neuroblastoma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Gregory H Reaman · National Childhood Cancer Foundation$84,462,747
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$58,436,699
- Larry Arthur$30,516,306
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
NeuroblastomaClinical ResearchHuman SubjectNeoplasm /Cancer ChemotherapyHuman Therapy EvaluationInterleukin 2Drug Screening /EvaluationNeoplasm /Cancer ImmunotherapyClinical Trial Phase IAntineoplasticsBone Marrow TransplantationAcute LeukemiaBrain NeoplasmsCancer Registry /ResourceCombination Cancer TherapyCombination ChemotherapyAcute Myelogenous LeukemiaCis Platinum CompoundChronic Myelogenous LeukemiaBiological Response ModifiersAcivicinAstrocytomaAdolescence (12-20)Child (0-11)
Grant awards (6)
DECITABINE (DAC) IN CHILDREN WITH RELAPSED OR REFRACTORY ACUTE LEUKEMIA$1,136
M01 · FY2005 · RR
ADVLOO18-Children's Oncology Group: A Phase I Trial$978
M01 · FY2004 · RR
Phase II Study of Irinotecan in Children with Refractory Solid Tumors$593
M01 · FY2004 · RR
PEDIATRIC ONCOLOGY GROUP$318,607
U10 · FY2002 · CA
PEDIATRIC ONCOLOGY GROUP$312,366
U10 · FY2001 · CA
PEDIATRIC ONCOLOGY GROUP$347,738
U10 · FY2000 · CA